Skip to main content
IBL HealthCare Limited logo

IBL HealthCare Limited — Investor Relations & Filings

Ticker · IBLHL ISIN · PK0095501018 PSX Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2026-04-30 Interim / Quarterly Rep…
Country PK Pakistan
Listing PSX IBLHL

About IBL HealthCare Limited

https://www.iblhc.com/

IBL HealthCare Limited is engaged in the marketing, selling, and distribution of a diverse range of healthcare products. Its portfolio encompasses world-class nutrition, medications, and medical devices. The company also owns brands and manages their manufacturing, often via tolling arrangements, rather than solely acting as a distributor. Key offerings include specialized nutritional solutions such as Enfa A+ Neuro Pro for pediatric nutrition and Oral IMPACT Powder for peri-operative surgery patients, alongside international brands like Equal Sucralose. IBL HealthCare's mission is to improve community well-being and quality of life through its comprehensive healthcare offerings.

Recent filings

Filing Released Lang Actions
Transmission of Quarterly Report for the Period Ended Mar 26
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive condensed interim financial report for the nine months ended March 31, 2026, including Directors’ Review, condensed interim statements of financial position, profit & loss, cash flows, changes in equity and notes. It contains actual unaudited financial statements and performance analysis for a period shorter than a fiscal year. This aligns with an Interim / Quarterly Report (IR). 9M 2026
2026-04-30 English
Financial Results for the quarter ended March 31, 2026
Interim / Quarterly Report Classification · 98% confidence The document is titled “Financial results for the third quarter ended March 31, 2026” and includes the full unaudited condensed interim financial statements (balance sheet, income statement, cash flows, and notes). It is not merely an earnings highlight or a publication notice, but the comprehensive interim/quarterly report itself. Therefore, it matches the definition for an Interim / Quarterly Report (code IR). 9M 2026
2026-04-29 English
Transmission of Quarterly Report for the Period Ended December 31, 2025
Regulatory Filings
2026-02-27 English
Financial Results for the Quarter Ended December 2025
Interim / Quarterly Report Classification · 94% confidence The document text contains full condensed interim financial statements (profit or loss, balance sheet, cash flow, changes in equity) for the half year ended December 31, 2025, including notes and management sign‐offs. It is a comprehensive interim (half-year) financial report, matching the definition of an Interim/Quarterly Report. It is not merely an announcement or certification, but the actual financial statements. H1 2026
2026-02-24 English
Presentation of Corporate Briefing Session
Investor Presentation Classification · 95% confidence The document is titled 'IBL HealthCare Limited Corporate Briefing Session' dated November 20, 2025. It contains a company overview, financial highlights for FY 2025, a financial snapshot with multi-year data, revenue and gross profit trends, future outlook, industry landscaping, and a Q&A section. The content is structured as a presentation with slides covering financial performance, business strategy, and outlook. There is no indication that this is a formal annual report, audit report, or regulatory filing. The presence of a Q&A session and the format strongly suggest this is a presentation given to investors or analysts. Therefore, the document best fits the category of an Investor Presentation (IP). The document length (6489 characters) supports a detailed presentation rather than a brief announcement or certification.
2025-11-19 English
Corporate Briefing Session 2025
AGM Information Classification · 95% confidence The document is a letter dated November 17, 2025, addressed to the General Manager of the Pakistan Stock Exchange. It announces details about a meeting scheduled for November 20, 2025, regarding the performance for the year ended June 30, 2025. The letter includes logistical details for attending the meeting physically or via video conferencing and instructions for attendees. The document does not contain any financial data, analysis, or detailed report content. It is an announcement about a meeting related to the annual performance, likely an Annual General Meeting (AGM) or a similar event. Given the short length (1629 characters) and the nature of the content (meeting announcement and instructions), this fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related meeting announcements. It is not a full Annual Report (10-K) or any other detailed financial report. Therefore, the classification is AGM-R with high confidence.
2025-11-17 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.